In many types of cancers, increased expression of SCD1 can lead to the proliferation and invasion of cancer cells, and inhibition of SCD1 expression can inhibit tumor progression in vivo, such as prostate cancer 100, bladder cancer 101, lung cancer 102 and clear cell kidney cell carcinoma 103. Here, SCD is linked to neoplasm.